Mark Henderson

Generic and brand name associations trade barbs as pharma R&D slips again in 2014

Mark Henderson
January 26, 2016

Another decline in R&D spending in 2014 by the Canadian pharmaceutical industry has set off a new round of counterclaims and recriminations. Data from the annual report of the Patented Medicines Prices Review Board (PMPRB) show that pharma R&D fell 1.

... Please become a Member or login to read the rest of this article ...


Other stories mentioning these organizations, people and topics

Other News

NSERC's Discovery Frontiers Initiative supports hydrogen gas research project

Genome Canada seeking renewed funding to strengthen applications-based research and pursue international partnerships

CIHR requests more funding as it grapples with fall-out from new competition structure

NSERC rejects CMC Microsystems proposal for continued funding support






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 0 free articles remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.